| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26612-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-17103-25ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-03654-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-22461-50ul | |||
![Immunohistochemistry: CRMP2 Antibody (20D8) [NBP3-26612] - Image of CRMP2 Antibody (20D8) diluted at 1:50 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.35% DAB.](http://images.novusbio.com/fullsize/nbp3-26612_rabbit-crmp2-mab-20d8-262202414471542.jpg "Immunohistochemistry: CRMP2 Antibody (20D8) [NBP3-26612] - Image of CRMP2 Antibody (20D8) diluted at 1:50 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a Goat anti-rabbit polymer IgG labeled by HRP and visualized using 0.35% DAB.")
![Immunocytochemistry/Immunofluorescence: CRMP2 Antibody (20D8) [NBP3-26612] - Staining of SH-SY5Y with CRMP2 Antibody (20D8) at 1:25, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 506-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26612_rabbit-crmp2-mab-20d8-282202412493633.jpg)
![Flow Cytometry: CRMP2 Antibody (20D8) [NBP3-26612] - Overlay Peak curve showing SH-SY5Y cells stained with CRMP2 Antibody (20D8) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26612_rabbit-crmp2-mab-20d8-282202414183684.jpg)
![Immunocytochemistry/Immunofluorescence: NMDAR2A Antibody [NBP2-19550] - NMDAR2A antibody [C1C2], Internal detects NMDAR2A protein by immunofluorescent analysis. Sample: DIV14 rat E18 primary cortical neurons were fixed in 4% paraformaldehyde at RT for 15 min. Green: NMDAR2A protein stained by NMDAR2A antibody [C1C2], Internal diluted at 1:500. Red: beta Tubulin 3/ Tuj1, stained by beta Tubulin 3/ Tuj1 antibody [GT1338] diluted at 1:500. Blue: Fluoroshield with DAPI.](http://images.novusbio.com/fullsize/NMDAR2A-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-19550-img0003.jpg "Immunocytochemistry/Immunofluorescence: NMDAR2A Antibody [NBP2-19550] - NMDAR2A antibody [C1C2], Internal detects NMDAR2A protein by immunofluorescent analysis. Sample: DIV14 rat E18 primary cortical neurons were fixed in 4% paraformaldehyde at RT for 15 min. Green: NMDAR2A protein stained by NMDAR2A antibody [C1C2], Internal diluted at 1:500. Red: beta Tubulin 3/ Tuj1, stained by beta Tubulin 3/ Tuj1 antibody [GT1338] diluted at 1:500. Blue: Fluoroshield with DAPI.")
![Immunohistochemistry-Paraffin: NMDAR2A Antibody [NBP2-19550] - Paraffin-embedded U87 xenograft. NMDAR2A antibody [C1C2], Internal dilution: 1:500.](http://images.novusbio.com/fullsize/NMDAR2A-Antibody-Immunohistochemistry-Paraffin-NBP2-19550-img0002.jpg)
![Immunohistochemistry-Paraffin: KCNH1 Antibody [NBP3-17103] - Staining of human cerebral cortex shows high expression.](http://images.novusbio.com/fullsize/KCNH1-Antibody-Immunohistochemistry-Paraffin-NBP3-17103-img0002.jpg "Immunohistochemistry-Paraffin: KCNH1 Antibody [NBP3-17103] - Staining of human cerebral cortex shows high expression.")
![Immunohistochemistry-Paraffin: KCNH1 Antibody [NBP3-17103] - Analysis in human cerebral cortex and liver tissues using Anti-KCNH1 antibody. Corresponding KCNH1 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/KCNH1-Antibody-Immunohistochemistry-Paraffin-NBP3-17103-img0001.jpg)
![Immunohistochemistry-Paraffin: KCNH1 Antibody [NBP3-17103] - Staining of human liver shows low expression as expected.](http://images.novusbio.com/fullsize/KCNH1-Antibody-Immunohistochemistry-Paraffin-NBP3-17103-img0003.jpg)
![Western Blot: NMDAR2C Splice Variant Antibody [NB300-116] - Western blot of 10 ug of HEK 293 cells expression. (Lane A) NR1-subunit that does not contain the NR1 Insert (Mock). (Lane B) NR1-subunit containing only the C2 Insert. (Lane C) NR1-subunit containing the C1 and C2 in sert. (Lane D) NR1-subunit containing the C1/C2' and N1/C2' insert.](http://images.novusbio.com/fullsize/NMDAR2C-Splice-Variant-Antibody-Western-Blot-NB300-116-img0003.jpg "Western Blot: NMDAR2C Splice Variant Antibody [NB300-116] - Western blot of 10 ug of HEK 293 cells expression. (Lane A) NR1-subunit that does not contain the NR1 Insert (Mock). (Lane B) NR1-subunit containing only the C2 Insert. (Lane C) NR1-subunit containing the C1 and C2 in sert. (Lane D) NR1-subunit containing the C1/C2' and N1/C2' insert.")
![Western Blot: NMDAR2B [p Tyr1252] Antibody [NB300-292] - Rat hippocampal lysate showing specific immunolabeling of the ~180k NR2B subunit phosphorylated at Tyr1252 (Control). Phosphospecificity is shown in the second lane (lambda-phosphatase: lambda-Ptase). The blot is identical to the control except that it was incubated in lambda-Ptase (1200 units for 30 min) before being exposed to the phospho-Tyr1252 NMDA NR2B subunit antibody. The immunolabeling is completely eliminated by treatment with lambda-Ptase.](http://images.novusbio.com/fullsize/NMDAR2B-[p-Tyr1252]-Antibody-Western-Blot-NB300-292-img0002.jpg "Western Blot: NMDAR2B [p Tyr1252] Antibody [NB300-292] - Rat hippocampal lysate showing specific immunolabeling of the ~180k NR2B subunit phosphorylated at Tyr1252 (Control). Phosphospecificity is shown in the second lane (lambda-phosphatase: lambda-Ptase). The blot is identical to the control except that it was incubated in lambda-Ptase (1200 units for 30 min) before being exposed to the phospho-Tyr1252 NMDA NR2B subunit antibody. The immunolabeling is completely eliminated by treatment with lambda-Ptase.")
![Immunohistochemistry: NMDAR2B [p Tyr1252] Antibody [NB300-292] - Immunostaining of 14 DIV rat cortical neurons showing NR2B phosphorylated at Tyr1252 in red and PSD95 in green. Photo courtesy of Gang Liu](http://images.novusbio.com/fullsize/NMDAR2B-[p-Tyr1252]-Antibody-Immunohistochemistry-NB300-292-img0003.jpg)
![Western Blot: NMDAR2B [p Ser1480] Antibody [NB100-61103] - Changes of NMDAR2B phosphorylation levels in the hippocampus and prefrontal cortex of P28 mice after earlylife propofol exposure. Typical results of western blot showed the changes in pSer1480 NMDAR2B phosphorylation levels in cytosol and particulate fractions of the hippocampus and prefrontal cortex of P28 mice after earlylife propofol exposure. D6 mice group treated with propofol (100 mg/kg body weight, i.p.) daily P6-P11; D1 mice group treated with propofil (100 mg/kg, i.p.) at P6 and then normal saline (10 mL/kg, i.p.) from P7-P11; N mice group received normal saline (10 mL/kg, i.p.) from P6-P11. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/28729940/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/NMDAR2B-[p-Ser1480]-Antibody-Western-Blot-NB100-61103-img0002.jpg "Western Blot: NMDAR2B [p Ser1480] Antibody [NB100-61103] - Changes of NMDAR2B phosphorylation levels in the hippocampus and prefrontal cortex of P28 mice after earlylife propofol exposure. Typical results of western blot showed the changes in pSer1480 NMDAR2B phosphorylation levels in cytosol and particulate fractions of the hippocampus and prefrontal cortex of P28 mice after earlylife propofol exposure. D6 mice group treated with propofol (100 mg/kg body weight, i.p.) daily P6-P11; D1 mice group treated with propofil (100 mg/kg, i.p.) at P6 and then normal saline (10 mL/kg, i.p.) from P7-P11; N mice group received normal saline (10 mL/kg, i.p.) from P6-P11. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/28729940/) licensed under a CC-BY license.")
![Western Blot: NMDAR2B [p Ser1480] Antibody [NB100-61103] - Rat hippocampal lysate showing specific immunolabeling of the ~180k NR2B subunit of the NMDAR phosphorylated at Ser1480 (Control). The phosphospecificity of this labeling is shown in the second lane (lambda-phosphatase: lambda-Ptase). The blot is identical to the control except that it was incubated in lambda-Ptase (1200 units for 30 min) before being exposed to the phospho-Ser1480 NMDA NR2B subunit antibody. The immunolabeling is completely eliminated by treatment with lambda-Ptase.](http://images.novusbio.com/fullsize/NMDAR2B-[p-Ser1480]-Antibody-Western-Blot-NB100-61103-img0001.jpg)
![Western Blot: FKTN Antibody [NBP1-33383] - Sample (30 ug of whole cell lysate) A: H1299 B: Hela 10% SDS PAGE; antibody diluted at 1:1000.](http://images.novusbio.com/fullsize/FKTN-Antibody-Western-Blot-NBP1-33383-img0003.jpg "Western Blot: FKTN Antibody [NBP1-33383] - Sample (30 ug of whole cell lysate) A: H1299 B: Hela 10% SDS PAGE; antibody diluted at 1:1000.")
![Immunocytochemistry/Immunofluorescence: FKTN Antibody [NBP1-33383] - Methanol-fixed HeLa, using FKTN antibody at 1:200 dilution.](http://images.novusbio.com/fullsize/FKTN-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-33383-img0002.jpg)
![Western Blot: SCN4B Antibody - BSA Free [NBP3-45427] - Mouse heart tissue were subjected to SDS PAGE followed by western blot with (SCN4B antibody) at dilution of 1:500](http://images.novusbio.com/fullsize/nbp3-45427_rabbit-scn4b-pab-bsa-free-28420251231270.jpg "Western Blot: SCN4B Antibody - BSA Free [NBP3-45427] - Mouse heart tissue were subjected to SDS PAGE followed by western blot with (SCN4B antibody) at dilution of 1:500")
![Immunohistochemistry: SCN4B Antibody - BSA Free [NBP3-45427] - Immunohistochemistry of paraffin-embedded human skeletal muscle tissue slide using (SCN4B Antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-45427_rabbit-scn4b-pab-bsa-free-28420251231298.jpg)
![Western Blot: FKTN Antibody [NBP1-59640] - Jurkat cell lysate, Antibody Titration: 5.0ug/ml](http://images.novusbio.com/fullsize/FKTN-Antibody-Western-Blot-NBP1-59640-img0001.jpg "Western Blot: FKTN Antibody [NBP1-59640] - Jurkat cell lysate, Antibody Titration: 5.0ug/ml")
![Immunohistochemistry-Paraffin: FKTN Antibody [NBP1-59640] - Human Muscle Tissue, Skeletal muscle cells (Indicated with Arrows) 4-8ug/ml.](http://images.novusbio.com/fullsize/FKTN-Antibody-Immunohistochemistry-Paraffin-NBP1-59640-img0003.jpg)
![Western Blot: HIP1 Related Antibody [NBP3-03654] - Analysis of extracts of various cell lines, using HIP1 Related antibody at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.](http://images.novusbio.com/fullsize/HIP1-Related-Antibody-Western-Blot-NBP3-03654-img0001.jpg "Western Blot: HIP1 Related Antibody [NBP3-03654] - Analysis of extracts of various cell lines, using HIP1 Related antibody at 1:3000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST.")
![Proximity Ligation Assay: NMDAR2B Antibody (2G5) [H00002904-M01] - Analysis of protein-protein interactions between CAPN1 and GRIN2B. HeLa cells were stained with anti-CAPN1 rabbit purified polyclonal 1:1200 and anti-GRIN2B mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/NMDAR2B-Antibody-2G5-Proximity-Ligation-Assay-H00002904-M01-img0002.jpg "Proximity Ligation Assay: NMDAR2B Antibody (2G5) [H00002904-M01] - Analysis of protein-protein interactions between CAPN1 and GRIN2B. HeLa cells were stained with anti-CAPN1 rabbit purified polyclonal 1:1200 and anti-GRIN2B mouse monoclonal antibody 1:50. Each red dot represents the detection of protein-protein interaction complex, and nuclei were counterstained with DAPI (blue).")
![Sandwich ELISA: NMDAR2B Antibody (2G5) [H00002904-M01] - Detection limit for recombinant GST tagged GRIN2B is approximately 3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/NMDAR2B-Antibody-2G5-Sandwich-ELISA-H00002904-M01-img0003.jpg)
![Western Blot: FKTN Antibody (SR1900) [NBP3-22461] - Western blot analysis using NBP3-22461 in HeLa cell lysate.](http://images.novusbio.com/fullsize/nbp3-22461_rabbit-fktn-mab-sr1900-572023162475.jpg "Western Blot: FKTN Antibody (SR1900) [NBP3-22461] - Western blot analysis using NBP3-22461 in HeLa cell lysate.")